Patents by Inventor Scott C. Baraban

Scott C. Baraban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372304
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Application
    Filed: June 26, 2023
    Publication date: November 23, 2023
    Inventor: Scott C. Baraban
  • Publication number: 20230346750
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 30, 2023
    Publication date: November 2, 2023
    Inventor: Scott C. Baraban
  • Patent number: 11684609
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: June 27, 2023
    Assignee: The Regents Of The University Of California
    Inventor: Scott C. Baraban
  • Patent number: 11648237
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: May 16, 2023
    Assignee: The Regents of the University of California
    Inventor: Scott C. Baraban
  • Patent number: 11564949
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: January 31, 2023
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Publication number: 20220226508
    Abstract: Provided, inter alia, are methods and compositions for treating epilepsy. In one aspect, provided herein is a method of selecting a compound for treating epilepsy, said method includes, contacting a test compound with 5-hydroxytryptamine-2B receptor (5-HT2B), and measuring the 5-HT2B agonistic activity of the test compound. In another aspect, provided herein is a method of treating an epilepsy in a subject in need thereof. The method includes administering to said subject an effective amount of a 5-HT2B specific receptor agonist.
    Type: Application
    Filed: May 28, 2020
    Publication date: July 21, 2022
    Inventors: Scott C. BARABAN, Aliesha L. GRIFFIN, Adam R. RENSLO, Priyadarshini JAISHANKAR
  • Patent number: 11291653
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: April 5, 2022
    Assignee: The Regents of the University of California
    Inventor: Scott C. Baraban
  • Publication number: 20210154171
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 28, 2020
    Publication date: May 27, 2021
    Inventor: Scott C. Baraban
  • Publication number: 20210060082
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 4, 2021
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Patent number: 10874643
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: December 29, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Scott C. Baraban
  • Publication number: 20200323825
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Application
    Filed: April 30, 2020
    Publication date: October 15, 2020
    Inventor: SCOTT C. BARABAN
  • Patent number: 10780131
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 22, 2020
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Patent number: 10695325
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: June 30, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Scott C. Baraban
  • Publication number: 20200147048
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 8, 2019
    Publication date: May 14, 2020
    Inventor: Scott C. Baraban
  • Publication number: 20190167642
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 6, 2019
    Inventor: Scott C. Baraban
  • Patent number: 10206953
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: February 19, 2019
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Publication number: 20190030084
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 31, 2019
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Publication number: 20180235937
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Application
    Filed: February 8, 2018
    Publication date: August 23, 2018
    Inventor: Scott C. Baraban
  • Patent number: 9925172
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using clemizole, a clemizole analog, or pharmaceutical salts thereof.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: March 27, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Scott C. Baraban
  • Publication number: 20180028499
    Abstract: Provided, inter alia, are methods for treating an epilepsy disorder using a 5HT receptor agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 1, 2018
    Inventor: Scott C. Baraban